Kenji Yogo

机构：Chugai Pharmaceutical Co., Ltd. (Japan)

发表论文 76 篇 · 总被引 1036 次 · h-index 19

代表论文

• Nicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic rats (2011 · Cardiovascular Diabetology · 被引 64)
• 22-Oxacalcitriol prevents progression of endothelial dysfunction through antioxidative effects in rats with type 2 diabetes and early-stage nephropathy (2012 · Nephrology Dialysis Transplantation · 被引 61)
• Vitamin D Receptor Signaling Enhances Locomotive Ability in Mice (2014 · Journal of Bone and Mineral Research · 被引 49)
• An orally active motilin receptor antagonist, MA-2029, inhibits motilin-induced gastrointestinal motility, increase in fundic tone, and diarrhea in conscious dogs without affecting gastric emptying (2009 · European Journal of Pharmacology · 被引 33)
• In vitro Pharmacological Characterization of Mitemcinal (GM-611), the First Acid-Resistant Non-Peptide Motilin Receptor Agonist, in Smooth Muscle of Rabbit Small Intestine (2006 · Pharmacology · 被引 31)
• Anti-IL-6 receptor antibody improves pain symptoms in mice with experimental autoimmune encephalomyelitis (2018 · Journal of Neuroimmunology · 被引 30)